Flexibly financing: Keeping up with technology advances doesn’t have to be overly costly

Chris Wilkinson, head of sales for Healthcare and Public Sector for Siemens Financial Services, UK, writes about the importance for pharma to keep up with technological advancements and how flexible financing can help.

The pharmaceutical industry contributes significantly to the UK economy. Pharmaceutical production has contributed almost 10% of the UK’s GDP, doubling since 1995. The industry has consistently produced a trade surplus, totalling £3 billion in 2014.¹ Similarly, investment in the sector continues to boom; the pharmaceutical industry is responsible for 25% of the total expenditure on research and development by UK businesses.²